首页> 美国卫生研究院文献>Gut and Liver >A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer

【2h】

A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer

机译：吉西他滨联合奥沙利铂治疗无法切除的胆囊癌的多中心II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsNo standard chemotherapy has been established for advanced gallbladder cancer. The authors studied the activity and tolerability of a gemcitabine and oxaliplatin (GEMOX) combination in unresectable gallbladder cancer (GBC).

机译：背景/目的尚未建立用于晚期胆囊癌的标准化学疗法。作者研究了吉西他滨和奥沙利铂（GEMOX）联合治疗不可切除的胆囊癌（GBC）的活性和耐受性。

著录项

期刊名称 Gut and Liver
作者
Sang Myung Woo; Sang Hyub Lee; Ji Won Yoo; Ki Young Yang; Jung Gyun Seo; Joo Kyung Park; Jin-Hyeok Hwang; Woo Jin Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon;
展开▼
作者单位

展开▼
年(卷),期 2013(7),5
年度 2013
页码 594–598
总页数 5
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Gallbladder neoplasms Gemcitabine Oxaliplatin;

机译：胆囊肿瘤;吉西他滨;奥沙利铂;

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer [J] . Sang Myung Woo, Sang Hyub Lee, Ji Won Yoo, Gut and Liver . 2013,第5期

机译：吉西他滨联合奥沙利铂治疗无法切除的胆囊癌的多中心II期试验
3. Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial [J] . Sharma Atul, Mohanti Bidhu Kalyan, Chaudhary Surendra Pal, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：改进的吉西他滨和奥氏牛肝蛋白或吉西他滨加顺铂在不可切除的胆囊癌中：III期随机对照试验的结果
4. Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer. [J] . Boeck S, Hoehler T, Seipelt G, Annals of oncology: official journal of the European Society for Medical Oncology . 2008,第2期

机译：卡培他滨加奥沙利铂（CapOx）与卡培他滨加吉西他滨（CapGem）与吉西他滨加奥沙利铂（mGemOx）：一项多中心随机II期晚期胰腺癌试验的最终结果。
5. Clinical studies of SP1049C, a polymer based anthracycline effective against drug resistant tumors. Results of phase II trial and pivotal phase Ⅲ program in upper gastrointestinal cancer indications [C] . Valery Alakhov Controlled Release Society Annual Meeting and Exposition . 2007

机译：SP1049C的临床研究，一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
6. Prospective Phase II Multicenter Registry of Ablation after Breast Lumpectomy Added to Extend (ABLATE) Intraoperative Margins in the Treatment of Breast Cancer [D] . Klimberg, V. Suzanne. 2017

机译：乳房肿块切除术后消融的前瞻性II期多中心消融术增加了扩大（ABLATE）术中切缘在治疗乳腺癌中的作用
7. Phase II study of gemcitabine oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer [O] . A F Hezel, M S Noel, J N Allen, 2014

机译：吉西他滨奥沙利铂联合帕尼单抗治疗KRAS野生型不可切除或转移性胆道癌和胆囊癌的II期研究
8. A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer [O] . Sang Myung Woo, Sang Hyub Lee, Ji Won Yoo, 2013

机译：吉西他滨加上奥沙利铂的多中心期II试验在不可切除的胆囊癌中

A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer

摘要

著录项

相似文献

相关主题

期刊订阅